Daptomycin in vitro susceptibility methodology: A review of methods, including determination of calcium in testing media

Clinical Microbiology Newsletter

Volumn 32, Issue 21, 2010, Pages 161-169

  Koeth, Laura M ^a   Thorne, Grace M ^b  

^a Laboratory Specialists Inc   (United States)

^b CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DAPTOMYCIN;

AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BROTH DILUTION; DISK DIFFUSION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPSILOMETER TEST; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 77957892423     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2010.10.001     Document Type: Article

References (43)

1. Cotroneo N., et al. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob. Agents Chemother. 2008, 52:2223-2225.
2. Silverman J.A., Perimutter N.G., Shapiro H.M. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 2003, 47:2538-2544.
3. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A8 2009, vol. 8. CLSI, Wayne, PA.
4. Koeth, L. and J. Difranco. 2008. Comparison of daptomycin Etest MICs on Mueller-Hinton, IsoSensititest and Brain-Heart Infusion agars with and without calcium supplementation to broth microdilution MICs against 20 Staphylococcus aureus isolates, abstr. P593 (CD-ROM). In Abstr. 18th Eur. Cong. Clin. Microbiol. Infect. Dis. 2008. European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain.
5. Koeth, L. and J. Difranco. 2008. Comparison of daptomycin Etest MICs on European Mueller Hinton and IsoSensitest agars against 20 Staphylococcus aureus., abstr. D-2221, p. 250. In Abstr. 48th Ann. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC) 2008 and the Infectious Diseases Society of America (IDSA) 46th Annual Meeting 2008. Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC.
6. International Standards Organization. 2006. Clinical laboratory testing and in vitro diagnostic test systems - susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility devices. Part 1: reference methods for testing the in vitro activity of antimicrobial agents against bacteria involved in infectious diseases. ISO/FDIS. 20776-1. http://www.iso.org.
7. Jones R.N., Barry A.L. Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations. Antimicrob. Agents Chemother. 1987, 31:625-629.
8. 2+ and albumin on these drugs. Antimicrob. Agents Chemother. 1991, 35:1710-1716.
9. Fuchs P.C., Barry A.L., Brown S.D. Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. Diagn. Microbiol. Infect. Dis. 2000, 38:51-58.
10. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. M100-S18 2009, vol. 19. CLSI, Wayne, PA.
11. Benson C.A., Beaudette F., Trenholm G. Comparative in vitro activity of LY146032, a new peptolide, with vancomycin and eight other agents against Gram-positive organisms. J. Antimicrob. Chemother. 1987, 20:191-196.
12. Food and Drug Administration, U.S.Dept.of Health and Human Services, and Center for Devices and Radiological Health 28 August 2009. Class II special controls guidance document antimicrobial susceptibility test (AST) systems; guidance for industry and FDA http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080564.htm.
13. Rennie, R. et al. 2005. Evaluation of MicroScan dried overnight panels compared to a NCCLS reference panel for daptomycin susceptibility testing with a challenge set of organisms, abstr. P1883 (CD-ROM). In Abstr. 18th Eur. Cong. Clin. Microbiol. Infect. Dis. 2005. European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark.
14. Johnston, J.A. et al. 2005. Detection of emerging daptomycin resistance in Enterococcus faecium and Staphylococcus aureus with MicroScan dried overnight Gram positive panels, abstr. D1639 (CD-ROM). In Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. 2005. Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA.
15. Messina-Powell S., et al. Evaluation of the VITEK and VITEK 2 systems for the susceptibility testing of Gram-positive cocci with daptomycin, abstr. C-005 (CD-ROM). Abstr. 105th Gen. Meet. Am. Soc. Microbiol. 2005 2005, American Society for Microbiology, Washington, DC.
16. Killian, S.B., C.C. Knapp, and N. Holliday. 2005. An evaluation of daptomycin using the Sensititre dried susceptibility plate for its effectiveness in detecting non-susceptible isolates, abstr. D1642 (CD-ROM). In Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. 2005. Interscience Conference on Antimicrobial Agents and Chemotherapry, Washington, DC.
17. Koeth L.M., Leclercq R., Olsson-Liljequist B. Comparison of daptomycin MIC results by DIN, NCCLS, SFM and SRGA methods for 297 Gram-positive organisms. Int. J. Antimicrob. Agents 2004, 23:17-24.
18. AB bioMérieux Etest Daptomycin (DPC) - technical variables that may cause discrepancies in MIC testing. CIS 014, M0000601 M10061. AB bioMérieux, Solna, Sweden http://www.abbiodisk.com.
19. Jevitt L.A., et al. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates. J. Clin. Microbiol. 2006, 44:3098-3104.
20. Jorgensen J.H., Crawford S.A. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs. J. Clin. Microbiol. 2006, 44:2126-2129.
21. Koeth, L.M. and J. Difranco. 2005. Comparison of daptomycin Etest MICs with broth microdilution MICs against a challenge set of 58 S. aureus and 44 Enterococcus spp., abstr. D1641 (CD-ROM). In Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother. 2005. Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC.
22. Friedrich L., et al. Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 2009, 65:306-311.
23. Fuchs P.C., Barry A.L., Brown S.D. Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media. J. Antimicrob. Chemother. 2001, 48:557-561.
24. Sader H.S., Rhomberg P.R., Jones R.N. Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53:3162-3165.
25. AB bioMérieux Etest package insert. 75001964-MH0277. AB bioMérieux, Solna, Sweden http://www.abbiodisk.com.
26. AB bioMérieux Etest customer information sheet. CIS 002 - Etest MIC end points for glycopeptides. M0000018-MH0187. AB bioMérieux, Solna, Sweden http://www.abbiodisk.com.
27. AB bioMérieux Etest technical manual (ETM). M0000448. AB bioMérieux, Solna, Sweden http://www.abbiodisk.com.
28. AB bioMérieux Etest customer information sheet. CIS 014 - daptomycin (DPC) - technical variables that cause discrepancies in MIC testing. M0000601 M10061. AB bioMérieux, Solna, Sweden http://www.abbiodisk.com.
29. AB bioMérieux Etest reading guide, aerobic bacteria ERG 001. M0000188-MH0266 http://www.abbiodisk.com.
30. Sader H.S., Jones R.N. Evaluation of daptomycin activity tested against 35,058 bacterial strains from hospitalized patients: summary of a 7 year surveillance program for North America (2002-2008), abstr. P199 (CD-ROM). Abstr. 47th Annu. Meet. Infect. Dis. Soc. Am. (IDSA) 2009 2009, Interscience Infectious Diseases Society of America, Phildelphia, PA.
31. Castanheira M., Jones R.N., Sader H.S. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006). Diagn. Microbiol. Infect. Dis. 2008, 61:235-239.
32. Biedenbach, R.N., D.J. Jones, and H.S. Sader. 2010 (pending). Antimicrobial susceptibility of daptomycin and comparator agents tested against bloodstream isolates of Staphylococcus aureus: analysis of a five-year trend in European medical centers (2005-2009). In Abstr. 20th European Cong. Clin. Microbiol. Infect. Dis. European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria.
33. Biedenbach D.J., et al. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Int. J. Antimicrob. Agents 2007, 30:143-149.
34. Rybak M.J., et al. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob. Agents Chemother. 2000, 44:1062-1066.
35. Fuchs P.C., Barry A.L., Brown S.D. In vitro bactericidal activity of daptomycin against staphylococci. J. Antimicrob. Chemother. 2002, 49467-49470.
36. Sader H.S., Fritsche T.R., Jones R.N. Daptomycin bactericidal activity and correlation between disk and broth microdiluton method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob. Agents Chemother. 2006, 50:2330-2336.
37. Wootton M., MacGowan A.P., Walsh T.R. Comparative bactericidal activity of daptomycin and vancomycin in Staphylococcus aureus with reduced susceptibility to glycopeptides (GISA) and heterogenous (h)GISA. Antimicrob. Agents Chemother. 2006, 50:4195-4197.
38. Holmes R.L., Jorgensen J.H. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. Antimicrob. Agents Chemother. 2008, 52:757-760.
39. Clinical and Laboratory Standards Institute Methods for determining bactericidal activity of antimicrobial agents. M26-A 1999, vol. 19. CLSI, Wayne, PA.
40. Moody J., Knapp C. Tests to assess bactericidal activity. Clinical microbiology procedures handbook 2007, xx. ASM Press, Washington, DC. L.S. Garcia, H.D. Isenberg (Eds.).
41. Lorian V. Susceptibility testing of antimicrobials in liquid media. Antibiotics in laboratory medicine 2005, 127-135. Lippincott Williams & Wilkins, Philadelphia, PA. V. Lorian (Ed.).
42. Katz B.D., Luperchio S.A., Thorne G.M. Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab prediffusion method. Diagn. Microbiol. Infect. Dis. 2008, 61:315-320.
43. Steenbergen J.N., Mohr J.F., Thorne G.M. Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. J. Antimicrob. Chemother. 2009, 64:1130-1138.